ORLANDO — Genetic testing is warranted in patients with epilepsy of unknown origin, new research suggests. Investigators found that pathogenic genetic variants were identified in over 40% of patients ...
Please provide your email address to receive an email when new articles are posted on . The study included 250 patients with epilepsy. A history of delayed development and earlier seizure onset were ...
Genetic testing results in lower length of stay in the neonatal intensive care unit (NICU) for infants with epilepsy, according to a study published in the journal Pediatric Neurology. The reduction ...
Please provide your email address to receive an email when new articles are posted on . A limited understanding of non-European DNA may hinder genetic testing interpretations, leading to disparities ...
GeneDx, a Stamford-based genomic testing firm formerly known as Sema4, said Wednesday it is launching a new program intended to increase access to exome sequencing for pediatric epilepsy patients.
Genetic testing results in lower length of stay in the neonatal intensive care unit (NICU) for infants with epilepsy, according to a study published in the journal Pediatric Neurology. The reduction ...
The largest and most diverse study to date of epilepsy's genetic factors has revealed new potential targets for treatment, both shared by and unique to different subtypes of epilepsy. The findings ...
Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new global study. Certain common genetic changes might make some people with ...
STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced the first-of-its-kind patient access ...
The steps involved in evaluating and diagnosing patients with epilepsy are complicated. In a new and extensive literature review of available information, experts provide insights on the valuable role ...
WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., an innovative molecular information company, announced today the release of a Next Generation Sequencing test focused on detection of ...
Scientists are moving toward a genetic test that could help thousands of mothers with epilepsy safely take life-saving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results